Insights

Image description

Superior front-end experience, improved patient outcomes will define Rite Aid's success

Revising year-end guidance on account of reimbursement rate headwinds, Rite Aid's stock took a hit after reporting second-quarter earnings even though the company beat analysts' consensus estimates for the quarter. The retail pharmacy operation recorded second-quarter profit of $127.8 million, or 13 cents per share, more than doubling FactSet consensus analyst estimate of 6 cents a share, according to a MarketWatch report. And while revenue of $6.5 billion was in line with analyst expectations, Rite Aid topped expected same-store sales growth of 3.3% by recording 4.1% in same-store sales growth. 
 
Rite Aid is still on the right track. 

Image description

KPMG survey: Retail executives embracing omnichannel approach

Many retail executives said their organizations have adopted an omnichannel strategy to link the consumers' in-store experience with the company's website, mobile device application and social media platforms in an effort to better respond to an increasingly online and mobile customer, according to KMPG’s 2014 Retail Outlook Survey.

Image description

New research report highlights benefit of pharmacist medications reviews

Canada's Premiers gathered in Charlottetown for the latest Council of the Federation meeting starting on Aug. 26, and health reform is a key topic. The pharmacy community is urging provinces to consider further expanding pharmacists' role as they can make important contributions to improving patient outcomes, reducing costs and ensuring the sustainability of the health care system.

Image description

What’s your strategy for diabetic patients?

"The diabetic is a critically important patient for pharmacies to serve. Yet, with increased Medicare audits, stringent compliance requirements and reduced reimbursements, is servicing these patients really worth it?" writes Kevin Dore, a director at Emdeon, in his latest blog.